![M. Wilsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Wilsey
Ordförande på
SAREPTA THERAPEUTICS, INC.
Förmögenhet: 5 M $ per 2026-05-31
Profil
M.
Kathleen Behrens Wilsey was the founder of Kew, Inc., founded in 2009, where the title held was President & Chief Executive Officer from 2012 to 2014.
Dr. Wilsey is also the founder of The Coalition for 21st Century Medicine.
Dr. Wilsey is currently Chairman at Sarepta Therapeutics, Inc. since 2015 and Chairman at MiMedx Group, Inc. since 2019.
Former positions include Chairman & President at National Venture Capital Association from 1993 to 2000, Independent Director at Amylin Pharmaceuticals, Inc. from 2011 to 2012, Managing Director & General Partner at Robertson Stephens & Co. in 1996, Independent Director at IGM Biosciences, Inc. from 2019 to 2025, Director at Abgenix, Inc. from 2001 to 2006, Director at Board On Science Technology & Economic Policy from 1997 to 2005, Consultant at RS Investment Management Co. LLC.
in 2009,.
and Member at President's Council of Advisors on Science & Technology from 2001 to 2009.
Education includes undergraduate and doctorate degrees from the University of California, Davis.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-04 | 224 357 ( 0,21 % ) | 4 M $ | 2026-05-31 | |
MIMEDX GROUP, INC. 0,14 % | 2025-06-18 | 212 771 ( 0,14 % ) | 782 997 $ | 2026-05-31 |
Aktiva positioner av M. Wilsey
| Företag | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Ordförande | 2015-04-16 |
| MIMEDX GROUP, INC. | Ordförande | 2019-06-19 |
Tidigare kända positioner av M. Wilsey
| Företag | Position | Slut |
|---|---|---|
| IGM BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2025-08-14 |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Verkställande Direktör | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direktör/Styrelseledamot | 2012-08-08 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Företagsledare/Principal | 2009-12-01 |
President's Council of Advisors on Science & Technology
 President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Företagsledare/Principal | 2009-01-01 |
M. Wilseys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
77
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Finance |
Robertson Stephens & Co.
 Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
President's Council of Advisors on Science & Technology
President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
The Coalition for 21st Century Medicine
 The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine's mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that will personalize patient care, improve patient outcomes, and substantially reduce healthcare costs. The company is based in Arlington, VA. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, and Patrick F. Terry. | Commercial Services |
Board On Science Technology & Economic Policy | |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
